by Dave Mihalovic

January 17, 2012

from PreventDisease Website

Spanish version



Dave Mihalovic is a Naturopathic Doctor who specializes in vaccine research, cancer prevention and a natural approach to treatment.


As the masses enjoy a steady awakening regarding the dangers and fraud that are vaccinations, the use of aerial vaccines and nano delivery systems are now being utilized and fully implemented by governments with little regard or consequence to human health.


Geo-engineering initiatives (commonly referred to as chemtrails)

are no longer considered discreet military operations,

and are finally admitted by goverments.

Aerial vaccines and nano delivery systems

are one of many geoengineering projects.


The use of aerial manned and unmanned vehicles for the aerial spraying under State and Federal mandates for vector control began under the Geneva Act for Chemical and Biological Weapons in 1949.


Over the years since its inception many amendments to this act and US parallel acts such as the,

  • Patriot Act of 2001

  • Space Preservation Act of 2001

  • Weather Modification Research and Technology Act of 2005,

...have included the following implementations under terrorist and riot control for aerial spraying of the mass population in selective city locations:

  • Weather Modification

  • Vector Control (insects, virus, and other similar vectors)

  • Mass Inoculations of the Public

Aerial vaccines are also directed towards animals by the use of plastic packets dropped by planes or helicopters.


Sanofi (who is one of the largest vaccine manufacturers in the world) has subsidiary companies such as Merial Limited who manufacture Raboral, an oral live-virus poisonous to humans yet distributed wildlife in the masses.

"In the United States, more than 12 million doses of RABORAL V-RG vaccine are used each year. Since the first use of RABORAL V-RG in the late 1980's, more than 100 million doses have been distributed around the world."

At the beginning of the year, a KVUE news report indicated that the Texas Department of State Health Services would initiate an aerial vaccine drop of 1.8 million doses in January alone.


Raboral V-RG is a poison because according to the material safety data sheet its ingestion, parenteral inoculation, droplet or aerosol exposure to mucous membranes or on broken skin is considered a health hazard exposed to infectious fluids or tissues.

In August 2009, during a similar autumn Raboral V-RG baiting campaign in western Pennsylvania, a woman aged 35 years who was taking immunosuppressive medication for inflammatory bowel disease contacted the Pennsylvania Department of Health (PADOH) after handling a ruptured bait, which had leaked liquid rabies vaccine onto a patch of abraded skin on her right hand.


The patient subsequently developed vaccinia virus infection and was treated with human vaccinia immune globulin intravenous (VIGIV) and an investigational antiviral agent.

Testing performed at CDC confirmed the presence of vaccinia virus DNA and rabies virus G protein DNA in papule material and serologic evidence of rabies virus neutralizing antibodies.


On day 6 of the infection, the papules had increased in number and size, and the patient was hospitalized. On day 9, she had 26 classic vaccinia virus lesions, including one on a site on her right arm that might not have been in contact with the vaccine initially.


On day 11, she experienced myalgia and headache; she had pronounced redness and edema in her right hand, accompanied by right axillary adenopathy.



A Greater Perspective on Aerial Spraying

The Defense Sciences Office of the Pathogen Countermeasures Program, in September 23, 1998 funded the University of Michigan's principal investigator, Dr. James Baker, Jr., Director of Michigan Nanotechnology Institute for Medicine and Biological Sciences under several DARPA grants.


Dr. Baker developed and focused on preventing pathogens from entering the human body, which is a major goal in the development of counter measures to Biological Warfare. This research project sought to develop a composite material that will serve as a pathogen avoidance barrier and post-exposure therapeutic agent to be applied in a topical manner to the skin and mucous membranes.


The composite is modeled after the immune system in that it involves redundant, non-specific and specific forms of pathogen defense and inactivation. This composite material is now utilized in many nasal vaccines and vector control through the use of hydro-gel, nanosilicon gels and actuator materials in vaccines.

Through Dr. Baker's research at the University of Michigan; he developed dendritic polymers and their application to medical and biological science.


He co-developed a new vector system for gene transfer using synthetic polymers. These studies have produced striking results and have the potential to change the basis of gene transfer therapy. Dendrimers are nanometer-sized water soluble polymers that can conjugate to peptides or arbohydrates to act as decoy molecules to inhibit the binding of toxins and viruses to cells.


They can act also as complex and stabilize genetic material for prolonged periods of time, as in a,

"time released or delayed gene transfer".

Through Dr. Baker's ground breaking research many pharmaceutical and biological pesticide manufacturers can use these principles in DNA vaccines specific applications that incorporate the Simian Monkey Virus SV40.



In 2008 Michael Greenwood wrote an article for the Yale School of Public Health entitled, "Aerial Spraying Effectively Reduces Incidence of West Nile Virus in Humans."


The article stated that the incidence of human West Nile virus cases can be significantly reduced through large scale aerial spraying that targets adult mosquitoes, according to research by the Yale School of Public Health and the California Department of Public Health.

Under the mandate for aerial spraying for specific vectors that pose a threat to human health, aerial vaccines known as DNA Vaccine Enhancements and Recombinant Vaccine against WNV may be tested or used to "protect" the people from vector infection exposures.


DNA vaccine enhancements specifically use Epstein-Barr viral capside's with multi human complement class II activators to neutralize antibodies.


The recombinant vaccines against WNV use Rabbit Beta-globulin or the poly (A) signal of the SV40 virus. In early studies of DNA vaccines it was found that the negative result studies would go into the category of future developmental research projects in gene therapy.


During the studies of poly (A) signaling of the SV40 for WNV vaccines, it was observed that WNV will lie dormant in individuals who were exposed to chicken pox, thus upon exposure to WNV aerial vaccines the potential for the release of chicken pox virus would cause a greater risk to having adult onset Shingles.



In February 2009 to present date, aerial spraying for the WNV occurred in major cities within the State of California.


During spraying of Anaheim, CA a Caucasian female (age 50) was exposed to heavy spraying, while doing her daily exercise of walking several miles. Heavy helicopter activity occurred for several days in this area. After spraying, she experienced light headedness, nausea, muscle aches and increased low back pain.


She was evaluated for toxicological mechanisms that were associated with pesticide exposure due to aerial spraying utilizing advanced biological monitoring testing.


The test results which included protein band testing utilizing Protein Coupled Response (PCR) methods were positive for KD-45. KD-45 is the protein band for SV-40 Simian Green Monkey virus. Additional tests were performed for Epstein-Barr virus capside and Cytomeglia virus which are used in bioengineering for gene delivery systems through viral protein envelope and adenoviral protein envelope technology.


The individual was positive for both; indicating a highly probable exposure to a DNA vaccination delivery system through nasal inhalation.



Pentagon Document Reveals Aerial Vaccination Plans

In the Quarterly FunVax Review in June, 2007, the report lists the objective of a project listed as ID: 149AZ2 as a preparation of a viral vector that will inhibit/decrease the expression of a specific disruption gene (VMAT2) within a human population.


It further indicates in the abstract that six method of virus dispersal were tested including high altitude release, water supply release, insect transmission, and various methods of diffusion.








Nano-Microchips Inside Vaccines?

Nanotechnology deals with structures smaller than one micrometer (less than 1/30th the width of a human hair), and involves developing materials or devices within that size.


To put the size of a nanometer in perspective, it is 100,000 times smaller than the width of a human hair.

The joint use of nanoelectronics, photolithography, and new biomaterials, have enabled the required manufacturing technology towards nanorobots for common medical applications, such as surgical instrumentation, diagnosis and drug delivery.

Depending on the objectives of studies, research could theoretically pave the way for smart recording electrodes that can deliver drugs to positively or negatively affect the immune response.

Through nanotechnology, researchers have also been able to create artificial pores able to transmit nanoscale materials through membranes.

A UC biomedical engineering study appearing in the journal Nature Nanotechnology, Sept. 27, 2009, successfully inserted the modified core of a nanomotor, a microscopic biological machine, into a lipid membrane. The resulting channel enabled them to move both single- and double-stranded DNA through the membrane.

Doug Dorst, a microbiologist and vaccine critic in South Wales, says these advances have an immense appeal to vaccine makers.

"Biotech companies and their researchers have quickly moved most funding initiatives towards nanotechnology to increase the potency of their vaccines," he said.

If microorganisms inside of vaccines can be coaxed into targeting or invading specific cells, they could achieve their goal at an accelerated rate over conventional vaccines.

"Depending on which side of the vaccine debate you're on, whether pro or con, nanobots inside vaccine preparations could advance their effectiveness exponentially by either dramatically improving or destroying immunity depending on their design," he added.

Dorst claims that present day nanobot technology could just as easily be used to advance biological weapons as they can to advance human health.

"For every fear that biotech propaganda proliferates about deadly diseases and how vaccines prevent them, it is one more lie to incrementally convince the masses that vaccines are effective."

The worry for Dorst is that one day vaccines,

"will do what they've always been intended for... control of the global populace."

We must be alert and attentive to plans for mass aerial vaccinations without informed consent.


Aerial spraying for vector control is not only for pesticide applications but for aerial vaccinations of wildlife and humans as stated in US Acts and Regulations. There is a real potential risk to exposure from aerial exposure to aerial DNA virus vaccines.


The risk certainly exceeds any benefits and only the public can stop this deliberate and irresponsible poisoning of populations.















Aerial Spraying Effectively Reduces Incidence of...

West Nile Virus in Humans

by Michael Greenwood

June 2008
from PublicHealth.Yale Website

recovered through WayBackMachine Website



The incidence of human West Nile virus cases can be significantly reduced through large-scale aerial spraying that targets adult mosquitoes, according to research by the Yale School of Public Health and the California Department of Public Health.

Ryan M. Carney, an M.P.H./M.B.A. student at Yale and the project’s lead researcher, examined infection rates in humans before and after planes applied an insecticide over two areas of Sacramento County, California.


The infection rate of people within the treated areas decreased significantly after spraying, compared to that within areas of the county that were not treated.

West Nile virus is transmitted to humans through the bite of an infected female mosquito and can lead to severe fever, encephalitis, paralysis and even death. The disease spread throughout all 58 counties of California in 2004, and Sacramento County was the area hardest hit in the United States in 2005.


The disease has appeared in all of the lower 48 states, with varying levels of intensity.

Over a period of several nights in the summer of 2005, two regions of the county measuring hundreds of square kilometers each were subjected to aerial spraying with the pyrethrin-based insecticide, EverGreen Crop Protection EC 60-6. It was the first time in state history that aerial insecticides had been applied over a large urban setting and that results were available from such well–defined application areas.

The two target areas had a combined population of 560,407 people. Prior to treatment, there were 48 documented cases of human infection from West Nile virus. The infection level fell to seven people following treatment with the insecticide and to zero post-incubation (14 days after treatment).


In contrast, the surrounding untreated areas (which had a combined population of 518,566 people) had 41 documented cases prior to treatment and 35 cases after spraying was completed in the treated areas.


The researchers concluded that the risk of infection in the untreated areas was approximately six times higher than it was in the treated areas after spraying.

“Aerial [spraying] is generally the most effective manner when the density of adult mosquito populations needs to be quickly reduced,” said Carney.


“This study provides the epidemiological framework for making more informed decisions and more rigorous evaluations of such treatments.”

The Sacramento-Yolo Mosquito and Vector Control District and California health officials decided to spray the two areas amidst a growing public health crisis in 2005 that had already resulted in several deaths statewide.


Still, the decision was controversial as some people in the targeted areas were concerned about possible side effects from such a large–scale application.


Some people in the untargeted areas, meanwhile, were upset that they were not being afforded the same protection as residents just a few miles away. The same insecticide is used on crops and has been approved by the U.S. Environmental Protection Agency.

Carney noted that if the decision is made to use aerial spraying, it is more effective to do it early in the West Nile virus transmission season, at the onset of amplification within mosquito and bird populations, rather than after human infection has set in.


The disease generally peaks in July and August.

Details of the research were published in the May issue of Emerging Infectious Diseases.